Sign inJoin waitlistJoin the waitlist

Dana Cardin

Assistant Professor of Medicine · Vanderbilt University Medical Center

Credentials: · · ·

History

Vanderbilt University Medical Center
Present
Vanderbilt University Medical Center
Present

Vanderbilt University Medical Center
2007–2009
Internal Medicine
Vanderbilt University Medical Center
2004–2006
Mount Sinai Medical Center
2003–2004
MD - University of North Carolina at Chapel Hill, 2003
University of North Carolina at Chapel Hill School of Medicine
1999–2003
University of North Carolina at Chapel Hill
1995–1999

Research

Pancreatic Adenocarcinoma, Version 2.2021, NCCN Clinical Practice Guidelines in Oncology
Journal of the National Comprehensive Cancer Network · 2021 · 1,081 citations
Pancreatic Adenocarcinoma, Version 2.2017, NCCN Clinical Practice Guidelines in Oncology
Journal of the National Comprehensive Cancer Network · 2017 · 795 citations
First-Line Nivolumab Plus Low-Dose Ipilimumab for Microsatellite Instability-High/Mismatch Repair-Deficient Metastatic Colorectal Cancer: The Phase II CheckMate 142 Study
Journal of Clinical Oncology · 2022 · 592 citations

Jordan Berlin
28 papers
Laura Goff
14 papers
ED
Efrat Dotan
8 papers
Kristen Ciombor
8 papers
Andrew Lowy
7 papers
Al Benson
6 papers
EC
Elena Chiorean
6 papers
SD
Satya Das
6 papers · 3 as a fellow
VC
Vincent Chung
6 papers
Cathy Eng
5 papers
Noelle LoConte
5 papers
Sushanth Reddy
5 papers

Clinical trials

Safety and Efficacy of Avelumab in Small Intestinal Adenocarcinoma
Principal investigator · Terminated · Phase 2
Vanderbilt-Ingram Cancer Center
2017–2021
Gemcitabine Hydrochloride, Dasatinib, and Erlotinib Hydrochloride in Treating Patients With Pancreatic Cancer That Is Metastatic or Cannot Be Removed by Surgery
Principal investigator · Active not recruiting · Phase 1
National Cancer Institute (NCI)
2012–2027
PhII Study STA-9090 as Second or Third-Line Therapy for Metastatic Pancreas Cancer
Principal investigator · Terminated · Phase 2
Vanderbilt-Ingram Cancer Center
2010–2013